Article ID Journal Published Year Pages File Type
6123660 Journal of Infection and Chemotherapy 2014 4 Pages PDF
Abstract
Interferon-beta plus ribavirin therapy was safe in elderly patients, with lower proportions of patients with a dose reduction of interferon-beta or ribavirin and treatment discontinuation. In treatment-naïve patients, the sustained virological response rate was similar between interferon-beta plus ribavirin therapy and pegylated interferon-alpha plus ribavirin therapy, regardless of whether the patients had hepatitis C virus genotype 1 or 2.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Preview
Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C
Authors
, , , ,